Build status - In Progress

Safety and Efficacy of IONIS-FB-Lrx in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Safety and Efficacy of IONIS-FB-Lrx in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Recruiting
55 years - 99 years
All
Phase 3
10 participants needed
1 Location

Brief description of study

The purpose of this study is to assess the Safety and Efficacy of IONIS-FB-Lrx patients with Geographic Atrophy secondary to Age Related Macular Degeneration

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Age-Related Macular Degeneration,AMD,Geographic Atrophy
  • Age: 55 years - 99 years
  • Gender: All

Male or Female. Over age 55, Well-demarcated Geographic Atrophy due to Age Related Macular Degeneration

Updated on 04 Aug 2024. Study ID: 832840

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center